Access

Article

Nature 445, 177-182 (11 January 2007) | doi:10.1038/nature05383; Received 8 August 2006; Accepted 25 October 2006; Published online 15 November 2006

Open Innovation Challenges

naturejobs

Thymosin bold beta4 induces adult epicardial progenitor mobilization and neovascularization

Nicola Smart1, Catherine A. Risebro1, Athalie A. D. Melville1, Kelvin Moses2, Robert J. Schwartz2, Kenneth R. Chien3 & Paul R. Riley1

  1. Molecular Medicine Unit, UCL Institute of Child Health, London WC1N 1EH, UK
  2. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA
  3. Massachusetts General Hospital Cardiovascular Research Center, Boston, Massachusetts 02114, USA, and the Department of Cell Biology, Harvard Medical School, and the Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA

Correspondence to: Paul R. Riley1 Correspondence and requests for materials should be addressed to P.R.R. (Email: P.Riley@ich.ucl.ac.uk).

Top

Cardiac failure has a principal underlying aetiology of ischaemic damage arising from vascular insufficiency. Molecules that regulate collateral growth in the ischaemic heart also regulate coronary vasculature formation during embryogenesis. Here we identify thymosin beta4 (Tbeta4) as essential for all aspects of coronary vessel development in mice, and demonstrate that Tbeta4 stimulates significant outgrowth from quiescent adult epicardial explants, restoring pluripotency and triggering differentiation of fibroblasts, smooth muscle cells and endothelial cells. Tbeta4 knockdown in the heart is accompanied by significant reduction in the pro-angiogenic cleavage product N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP). Although injection of AcSDKP was unable to rescue Tbeta4 mutant hearts, it significantly enhanced endothelial cell differentiation from adult epicardially derived precursor cells. This study identifies Tbeta4 and AcSDKP as potent stimulators of coronary vasculogenesis and angiogenesis, and reveals Tbeta4-induced adult epicardial cells as a viable source of vascular progenitors for continued renewal of regressed vessels at low basal level or sustained neovascularization following cardiac injury.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

VEGF gene therapy: stimulating angiogenesis or angioma-genesis?

Nature Medicine News and Views (01 Oct 2000)

Cre-constructing the heart

Nature Genetics News and Views (01 Jan 2003)